Opportunity Radar

← Back to search

Grant

Expanding the Target Landscape by Drugging the Undruggable (R21 Clinical Trial Not Allowed)

View on Grants.gov ↗ Sign in to save

Type
Grant
Notice type
G
Agency
National Institutes of Health
Sub-agency
HHS-NIH11
Solicitation #
PAR-25-442
Posted
Jun 17, 2025
Response due
Feb 17, 2028
Archive date
Mar 24, 2028
CFDA / Assistance listing
93.121,93.242,93.350,93.855,93.865,93.867
Contact
grantsinfo@nih.gov
Source
Grants.gov

Description

The purpose of this Notice of Funding Opportunity (NOFO) is to solicit applications for exploratory and early-stage projects that focus on undruggable target classes within intractable human disease. Applicants will identify a human disease relevant undruggable target class and develop a method or agent that is selective for one or more targets within that target class. This NOFO is intended to jumpstart research that demonstrates innovative strategies to modulate targets that cannot be addressed by established therapeutic types, furthering the development of methods and/or agents selective for undruggable target classes.

Similar open opportunities